EUR 7.64
(9.46%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -935.5 Thousand EUR | 37.06% |
2022 | 1.61 Million EUR | 85.32% |
2021 | 842.64 Thousand EUR | 201.16% |
2020 | -1.05 Million EUR | 78.88% |
2019 | -4.74 Million EUR | 6.49% |
2018 | -5.06 Million EUR | 4.13% |
2017 | -5.25 Million EUR | 16.97% |
2016 | -6.32 Million EUR | 21.47% |
2015 | -8.05 Million EUR | -13.51% |
2014 | -7.09 Million EUR | -69.03% |
2013 | -4.19 Million EUR | -81.55% |
2012 | -2.31 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -466.5 Thousand EUR | 0.0% |
2023 FY | - EUR | 37.06% |
2023 Q2 | -1.07 Million EUR | -100.02% |
2023 Q3 | 275.62 Thousand EUR | 125.57% |
2023 Q1 | -538.95 Thousand EUR | 55.64% |
2023 Q4 | 551.3 Thousand EUR | 100.02% |
2022 Q3 | -731.93 Thousand EUR | -128.67% |
2022 Q4 | -1.21 Million EUR | -65.98% |
2022 Q2 | 2.55 Million EUR | 99.99% |
2022 FY | - EUR | 85.32% |
2022 Q1 | 1.27 Million EUR | 375.02% |
2021 Q2 | -730.1 Thousand EUR | -100.03% |
2021 FY | - EUR | 201.16% |
2021 Q4 | -464.1 Thousand EUR | -110.12% |
2021 Q3 | -220.87 Thousand EUR | 69.75% |
2021 Q1 | -365 Thousand EUR | 72.31% |
2020 Q3 | -673.84 Thousand EUR | 59.09% |
2020 Q2 | -1.64 Million EUR | -100.0% |
2020 Q1 | -823.6 Thousand EUR | 70.96% |
2020 FY | - EUR | 78.88% |
2020 Q4 | -1.31 Million EUR | -95.64% |
2019 Q3 | -1.43 Million EUR | 54.48% |
2019 FY | - EUR | 6.49% |
2019 Q1 | -1.57 Million EUR | 5.68% |
2019 Q2 | -3.15 Million EUR | -100.03% |
2019 Q4 | -2.83 Million EUR | -97.41% |
2018 Q1 | -1.29 Million EUR | 13.01% |
2018 FY | - EUR | 4.13% |
2018 Q4 | -1.67 Million EUR | 0.0% |
2018 Q2 | -1.29 Million EUR | 0.0% |
2018 Q3 | -1.67 Million EUR | -29.67% |
2017 Q3 | -1.48 Million EUR | -27.94% |
2017 FY | - EUR | 16.97% |
2017 Q2 | -1.15 Million EUR | 0.0% |
2017 Q1 | -1.15 Million EUR | 4.06% |
2017 Q4 | -1.48 Million EUR | 0.0% |
2016 Q2 | -1.97 Million EUR | 0.0% |
2016 Q4 | -1.2 Million EUR | 0.0% |
2016 FY | - EUR | 21.47% |
2016 Q3 | -1.2 Million EUR | 38.71% |
2016 Q1 | -1.97 Million EUR | 25.26% |
2015 Q4 | -2.63 Million EUR | 0.0% |
2015 Q3 | -2.63 Million EUR | -10.89% |
2015 FY | - EUR | -13.51% |
2015 Q1 | -2.37 Million EUR | -5.77% |
2015 Q2 | -2.37 Million EUR | 0.0% |
2014 Q3 | -2.24 Million EUR | -51.0% |
2014 FY | - EUR | -69.03% |
2014 Q4 | -2.24 Million EUR | 0.0% |
2014 Q2 | -1.48 Million EUR | 0.0% |
2014 Q1 | -1.48 Million EUR | -58.9% |
2013 Q3 | -937.4 Thousand EUR | 21.95% |
2013 Q4 | -937.4 Thousand EUR | 0.0% |
2013 Q2 | -1.2 Million EUR | 0.0% |
2013 FY | - EUR | -81.55% |
2013 Q1 | -1.2 Million EUR | -100.76% |
2012 FY | - EUR | 0.0% |
2012 Q1 | -598.26 Thousand EUR | 0.0% |
2012 Q2 | -598.26 Thousand EUR | 0.0% |
2012 Q3 | -598.26 Thousand EUR | 0.0% |
2012 Q4 | -598.26 Thousand EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | -3.14 Million EUR | 70.298% |
Modulight Oyj | -10.44 Million EUR | 91.043% |
Revenio Group Oyj | 30.09 Million EUR | 103.109% |